NCT03524235 Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL Status COMPLETED Phase PHASE1
NCT03515174 Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO Status COMPLETED Phase NA
NCT03502733 Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03494296 A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL Status RECRUITING Phase N/A
NCT03489369 Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas Status COMPLETED Phase PHASE1
NCT03489343 Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas Status COMPLETED Phase PHASE1
NCT03488160 CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma Status UNKNOWN Phase NA
NCT03480360 Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression Status COMPLETED Phase PHASE3
NCT03476070 Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS) Status UNKNOWN Phase N/A
NCT03468153 Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT03465891 Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma Status TERMINATED Phase PHASE2
NCT03454945 Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides Status UNKNOWN Phase PHASE3
NCT03451825 Phase I/II Study of Avelumab in Pediatric Cancer Participants Status TERMINATED Phase PHASE1
NCT03436342 Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma Status UNKNOWN Phase EARLY_PHASE1
NCT03435250 Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss Status TERMINATED Phase PHASE1
NCT03422874 Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma Status WITHDRAWN Phase PHASE1
NCT03408561 Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer Status WITHDRAWN Phase NA
NCT03407430 Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain Status TERMINATED Phase PHASE2
NCT03383055 CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig Status COMPLETED Phase PHASE1